Literature DB >> 32836820

The COVID-19 pandemic: model-based evaluation of non-pharmaceutical interventions and prognoses.

Alex De Visscher1.   

Abstract

An epidemiological model for COVID-19 was developed and implemented in MATLAB/GNU Octave for use by public health practitioners, policy makers, and the general public. The model distinguishes four stages in the disease: infected, sick, seriously sick, and better. The model was preliminarily parameterized based on observations of the spread of the disease. The model assumes a case mortality rate of 1.5%. Preliminary simulations with the model indicate that concepts such as "herd immunity" and containment ("flattening the curve") are highly misleading in the context of this virus. Public policies based on these concepts are inadequate to protect the population. Only reducing the R 0 of the virus below 1 is an effective strategy for maintaining the death burden of COVID-19 within the normal range of seasonal flu. The model is illustrated with the cases of Italy, France, and Iran and is able to describe the number of deaths as a function of time in all these cases although future projections tend to slightly overestimate the number of deaths when the analysis is made early on. The model can also be used to describe reopenings of the economy after a lockdown. The case mortality rate is still prone to large uncertainty, but modeling combined with an investigation of blood donations in The Netherlands imposes a lower limit of 1%. © Springer Nature B.V. 2020.

Entities:  

Keywords:  Case mortality rate; Doubling time; Herd immunity; R0; SARS-CoV-2; Social distancing

Year:  2020        PMID: 32836820      PMCID: PMC7416305          DOI: 10.1007/s11071-020-05861-7

Source DB:  PubMed          Journal:  Nonlinear Dyn        ISSN: 0924-090X            Impact factor:   5.022


  13 in total

1.  Strategies for containing an emerging influenza pandemic in Southeast Asia.

Authors:  Neil M Ferguson; Derek A T Cummings; Simon Cauchemez; Christophe Fraser; Steven Riley; Aronrag Meeyai; Sopon Iamsirithaworn; Donald S Burke
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

2.  Seasonal influenza in the United States, France, and Australia: transmission and prospects for control.

Authors:  G Chowell; M A Miller; C Viboud
Journal:  Epidemiol Infect       Date:  2007-07-18       Impact factor: 2.451

Review 3.  The reproductive number of COVID-19 is higher compared to SARS coronavirus.

Authors:  Ying Liu; Albert A Gayle; Annelies Wilder-Smith; Joacim Rocklöv
Journal:  J Travel Med       Date:  2020-03-13       Impact factor: 8.490

4.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

5.  Serial interval of novel coronavirus (COVID-19) infections.

Authors:  Hiroshi Nishiura; Natalie M Linton; Andrei R Akhmetzhanov
Journal:  Int J Infect Dis       Date:  2020-03-04       Impact factor: 3.623

6.  A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action.

Authors:  Qianying Lin; Shi Zhao; Daozhou Gao; Yijun Lou; Shu Yang; Salihu S Musa; Maggie H Wang; Yongli Cai; Weiming Wang; Lin Yang; Daihai He
Journal:  Int J Infect Dis       Date:  2020-03-04       Impact factor: 3.623

7.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

8.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

9.  Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020.

Authors:  K Roosa; Y Lee; R Luo; A Kirpich; R Rothenberg; J M Hyman; P Yan; G Chowell
Journal:  Infect Dis Model       Date:  2020-02-14
View more
  6 in total

Review 1.  Non-pharmaceutical interventions during the COVID-19 pandemic: A review.

Authors:  Nicola Perra
Journal:  Phys Rep       Date:  2021-02-13       Impact factor: 25.600

2.  Mathematical model of COVID-19 with comorbidity and controlling using non-pharmaceutical interventions and vaccination.

Authors:  Parthasakha Das; Ranjit Kumar Upadhyay; Arvind Kumar Misra; Fathalla A Rihan; Pritha Das; Dibakar Ghosh
Journal:  Nonlinear Dyn       Date:  2021-05-19       Impact factor: 5.022

3.  Heterogeneity matters: Contact structure and individual variation shape epidemic dynamics.

Authors:  Gerrit Großmann; Michael Backenköhler; Verena Wolf
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

4.  Two Chemical Engineers Look at the COVID-19 Pandemic.

Authors:  Alex De Visscher; Paôlla Chrystine Pinheiro Patrício
Journal:  Can J Chem Eng       Date:  2022-07-16       Impact factor: 2.500

5.  On the effectiveness of COVID-19 restrictions and lockdowns: Pan metron ariston.

Authors:  Leonidas Spiliopoulos
Journal:  BMC Public Health       Date:  2022-10-01       Impact factor: 4.135

6.  Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.

Authors:  Mahesh Jayaweera; Chamath Dannangoda; Dilum Dilshan; Janith Dissanayake; Hasini Perera; Jagath Manatunge; Buddhika Gunawardana
Journal:  Infect Dis Model       Date:  2021-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.